Northern Biologics Announces Phil Vickers as New CEO

Ontario Industry Updates
Written By Guest User

Northern Biologics Inc., a developer of first‐in‐class immuno‐oncology products, announced Philip Vickers, Ph.D., formerly of global head of R&D for Shire, will be joining the company as CEO and a member of the board. Stefan Larson, Ph.D., who served as Northern Biologics’ founding CEO since 2014, will remain on the company’s board.

Read the full release here.

Guest User
Previous

Fundraising Event: Saving Sight in an Aging World
Next

OBIO Health Economics Day: Presentation Videos Available Now